PIONEER: Prediction of Duration of Mechanical Ventilation in ARDS

Sponsor
Dr. Negrin University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05993377
Collaborator
Unity Health Toronto (Other), Cardiff University (Other), Leiden University Medical Center (Other)
1,303
20
3.6
65.2
18.2

Study Details

Study Description

Brief Summary

The investigators are planning to perform a secondary analysis of an academic dataset of 1,303 patients with moderate-to-severe acute respiratory distress syndrome (ARDS) included in several published cohorts (NCT00736892, NCT022288949, NCT02836444, NCT03145974), aimed to characterize the best early scenario during the first three days of diagnosis to predict duration of mechanical ventilation in the intensive care unit (ICU) using supervised machine learning (ML) approaches.

Condition or Disease Intervention/Treatment Phase
  • Other: Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .

Detailed Description

The acute respiratory distress syndrome (ARDS) is an important cause of morbidity, mortality, and costs in intensive care units (ICUs) worldwide. Most ARDS patients require mechanical ventilation (MV). Few studies have investigated the prediction of MV duration of ARDS.

For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented [Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.

Study Design

Study Type:
Observational
Actual Enrollment :
1303 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Predicting Length of Mechanical Ventilation in Moderate-to-severe Acute Respiratory Distress Syndrome Using Machine Learning
Actual Study Start Date :
Aug 14, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Derivation and testing cohort

It will contain 1000 ARDS patients

Other: Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
we will use robust machine learning approaches, such as Random Forest and XGBoost.

Confirmatory cohort

It will contain 303 patients (for external validation)

Other: Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
we will use robust machine learning approaches, such as Random Forest and XGBoost.

Outcome Measures

Primary Outcome Measures

  1. Days on mechanical ventilation [from diagnosis to extubation]

    Duration of mechanical ventilation

Secondary Outcome Measures

  1. ICU mortality [up to 24 weeks]

    mortality in the intensive care unit

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Berlin criteria for moderate to severe acute respiratory distress syndrome
Exclusion Criteria:
  • Postoperative patients ventilated <24h

  • brain death patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Universitario Dr. Negrin Las Palmas De Gran Canaria Las Palmas Spain 35019
2 Hospital Universitario Puerta de Hierro (ICU) Majadahonda Madrid Spain 28222
3 Hospital Universitario NS de Candelaria Santa Cruz de Tenerife Tenerife Spain
4 Hospital NS del Prado Talavera de la Reina Toledo Spain
5 Complejo Hospitalario Universitario de Albacete (ICU) Albacete Spain 02006
6 Complejo Hospitalario de Albacete Albacete Spain
7 Department of Anesthesia, Hospital Clinic Barcelona Spain 08036
8 Hospital General de Ciudad Real (ICU) Ciudad Real Spain 13005
9 Hospital Virgen de La Luz Cuenca Spain
10 Hospital Universitario de A Coruña (ICU) La Coruña Spain 15006
11 Complejo Hospitalario Universitario de León León Spain
12 Hospital Universitario Ramón y Cajal (Anesthesia) Madrid Spain 28034
13 Hospital Universitario La Paz (ICU) Madrid Spain 28046
14 Hospital Fundación Jiménez Díaz Madrid Spain
15 Hospital Universitario Virgen de Arrixaca (ICU) Murcia Spain 30120
16 Hospital Universitario Regional de Malaga Carlos Haya (ICU) Málaga Spain 29010
17 Hospital Universitario Carlos Haya Málaga Spain
18 Hospital Universitario Río Hortega (ICU) Valladolid Spain 47012
19 Hospital Virgen de la Concha (ICU) Zamora Spain 49022
20 Cardiff University Cardiff United Kingdom

Sponsors and Collaborators

  • Dr. Negrin University Hospital
  • Unity Health Toronto
  • Cardiff University
  • Leiden University Medical Center

Investigators

  • Principal Investigator: Jesús Villar, Hospital Universitario D. Negrin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jesus Villar, principal investigator, Dr. Negrin University Hospital
ClinicalTrials.gov Identifier:
NCT05993377
Other Study ID Numbers:
  • PIFIISC21-36
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jesus Villar, principal investigator, Dr. Negrin University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2023